Chemomab Therapeutics Ltd. (CMMB) › Capital ExpendituresChemomab Therapeutics Ltd. (CMMB) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $213.0K2019: $95.0K2020: $38.0K2021: $239.0K2022: $68.0K2023: $3.0K2024: $02025: $3.0K$3.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$3.0K—2024$0-100.0%2023$3.0K-95.6%2022$68.0K-71.5%2021$239.0K+528.9%2020$38.0K-60.0%2019$95.0K-55.4%2018$213.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share